These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1322512)

  • 1. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks.
    Caekebeke JF; Ferrari MD; Zwetsloot CP; Jansen J; Saxena PR
    Neurology; 1992 Aug; 42(8):1522-6. PubMed ID: 1322512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs.
    Diener HC; Peters C; Rudzio M; Noe A; Dichgans J; Haux R; Ehrmann R; Tfelt-Hansen P
    J Neurol; 1991 Aug; 238(5):245-50. PubMed ID: 1655985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumatriptan and cerebral blood flow velocity changes during migraine attacks.
    Totaro R; De Matteis G; Marini C; Baldassarre M; Carolei A
    Headache; 1997; 37(10):635-9. PubMed ID: 9439084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine.
    Limmroth V; May A; Auerbach P; Wosnitza G; Eppe T; Diener HC
    J Neurol Sci; 1996 Jun; 138(1-2):60-5. PubMed ID: 8791240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan.
    Friberg L; Olesen J; Iversen HK; Sperling B
    Lancet; 1991 Jul; 338(8758):13-7. PubMed ID: 1676084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache.
    Diener HC; Haab J; Peters C; Ried S; Dichgans J; Pilgrim A
    Headache; 1991 Apr; 31(4):205-9. PubMed ID: 1646775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of migraine attacks with sumatriptan.
    Subcutaneous Sumatriptan International Study Group
    N Engl J Med; 1991 Aug; 325(5):316-21. PubMed ID: 1647495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan.
    den Boer MO; Villalón CM; Heiligers JP; Humphrey PP; Saxena PR
    Br J Pharmacol; 1991 Feb; 102(2):323-30. PubMed ID: 1849764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects and mechanism of action of sumatriptan in migraine.
    Ferrari MD; Saxena PR
    Clin Neurol Neurosurg; 1992; 94 Suppl():S73-7. PubMed ID: 1320526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mode of action of sumatriptan is vascular? A debate.
    Humphrey PP; Goadsby PJ
    Cephalalgia; 1994 Dec; 14(6):401-10; discussion 393. PubMed ID: 7697699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan in the treatment of acute migraine with aura.
    Banerjee M; Findley LJ
    Cephalalgia; 1992 Feb; 12(1):39-44. PubMed ID: 1313746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group.
    Visser WH; Ferrari MD; Bayliss EM; Ludlow S; Pilgrim AJ
    Cephalalgia; 1992 Oct; 12(5):308-13. PubMed ID: 1330318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for the use of 5-HT1-like agonists in the treatment of migraine.
    Feniuk W; Humphrey PP; Perren MJ; Connor HE; Whalley ET
    J Neurol; 1991; 238 Suppl 1():S57-61. PubMed ID: 1646289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries.
    Hamel E; Fan E; Linville D; Ting V; Villemure JG; Chia LS
    Mol Pharmacol; 1993 Aug; 44(2):242-6. PubMed ID: 8394988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumatriptan in the treatment of migraine.
    Ferrari MD
    Neurology; 1993 Jun; 43(6 Suppl 3):S43-7. PubMed ID: 8389011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial Doppler in migraine attacks before and after treatment with oral zolmitriptan or sumatriptan.
    Thomaides T; Karagounakis D; Spantideas A; Katelanis S
    Headache; 2003 Jan; 43(1):54-8. PubMed ID: 12864759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute migraine with subcutaneous sumatriptan.
    Cady RK; Wendt JK; Kirchner JR; Sargent JD; Rothrock JF; Skaggs H
    JAMA; 1991 Jun; 265(21):2831-5. PubMed ID: 1851894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
    Goadsby PJ; Edvinsson L
    Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache.
    Dechant KL; Clissold SP
    Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model.
    Schmetterer L; Wolzt M; Krejcy K; Graselli U; Findl O; Eichler HG; Singer EA
    Clin Pharmacol Ther; 1996 Aug; 60(2):199-205. PubMed ID: 8823238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.